Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Clovis Oncology Inc. (CLVS)

9.21   0.07 (0.77%) 01-23 16:00
Open: 9.03 Pre. Close: 9.14
High: 9.6199 Low: 8.85
Volume: 6,042,786 Market Cap: 669M
Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.625 - 9.672 9.672 - 9.72
Low: 8.745 - 8.791 8.791 - 8.838
Close: 9.134 - 9.209 9.209 - 9.285

Technical analysis

as of: 2020-01-23 4:37:45 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 12.70     One year: 14.69
Support: Support1: 8.11    Support2: 6.75
Resistance: Resistance1: 10.87    Resistance2: 12.58
Pivot: 9.46
Moving Average: MA(5): 9.40     MA(20): 9.84
MA(100): 7.13     MA(250): 13.64
MACD: MACD(12,26): -0.29     Signal(9): -0.19
Stochastic oscillator: %K(14,3): 35.25     %D(3): 38.88
RSI: RSI(14): 46.05
52-week: High: 32.05  Low: 2.93  Change(%): -62.4
Average Vol(K): 3-Month: 1191572  10-Days: 1114051

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
CLVS has closed above bottom band by 39.4%. Bollinger Bands are 38.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 15 Jan 2020 20:23:34 +0000
Notable Wednesday Option Activity: CLVS, OKTA, TTD

Wed, 15 Jan 2020 17:41:00 +0000
Here's Why Clovis Oncology Rose as Much as 25.6% Today

Wed, 15 Jan 2020 16:35:00 +0000
FDA Gives Clovis Oncology's Rubraca a Priority Review

Sat, 11 Jan 2020 15:00:00 +0000
All the 2020 Pre-JPM News Healthcare Investors Need to Know

Thu, 09 Jan 2020 01:47:05 +0000
FDA Nod For MRK, All Eyes On AGTC, ACTION Boosts APLT

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 72.59
Shares Float (M) 48.95
% Held by Insiders 3.09
% Held by Institutions 106.34
Shares Short (K) 27430
Shares Short P. Month (K)

Stock Financials

EPS -7.500
Book Value (p.s.) -1.600
PEG Ratio -0.04
Profit Margin -298.53
Operating Margin -277.97
Return on Assets (ttm) -29.0
Return on Equity (ttm) -547.5
Qtrly Rev. Growth 65.2
Gross Profit (p.s.) 1.046
Sales Per Share
EBITDA (p.s.) -5.025
Qtrly Earnings Growth
Operating Cash Flow (M) -336.20
Levered Free Cash Flow (M) -146.19

Stock Valuations

P/E -1.23
P/E Growth Ratio 0.01
P/BV -5.76
P/S 3.66
P/CF -1.99

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.